CLEVELAND ACUTE STROKE EXPERIENCE Cleveland Health Quality Choice –stroke data collected by trained abstractors since 1991 –IV tPA datapoints added 1996.

Slides:



Advertisements
Similar presentations
Patient Recruitment Patient Recruitment Thomas Devlin, MD PhD Erlanger Southeast Regional Stroke Center.
Advertisements

3/28/2017© 2009, American Heart Association. All rights reserved.
Heather M. Prendergast, MD, MPH EMRA/FERNE Case Conference: Legal Issues in the ED Management of Acute Ischemic Stroke Patients.
Accomplishments in Stroke Care
TPA in Stroke: What's All the Fuss?. FERNE Brain Illness and Injury Course.
TPA… SMART or not SMART? That is the Question. Sarah Parker, MD.
Hyperacute Stroke Treatment: Inclusion and Exclusion Criteria
Target: Stroke Building on Success A national quality improvement initiative of the American Heart Association/American Stroke Association to improve.
EM TREATMENT OF ACUTE STROKE Progress, Problems, Politics William G. Barsan, M.D. University of Michigan.
Emily O’Brien, MSPH Predoctoral Trainee February 16, 2010 The North Carolina Stroke Care Collaborative Clinical Outcomes among Stroke Patients Receiving.
Clinical Use of tPA in Acute Ischemic Stroke Edward P. Sloan, MD, MPH Associate Professor Department of Emergency Medicine University of Illinois College.
E. Bradshaw Bunney, MD Legal Issues in the ED Management of Acute Ischemic Stroke Patients.
“ Remember that stroke patient you treated last night…” What to Expect following tPA Use in Acute Ischemic Stroke The INSTINCT Trial NIH / NINDS R01 NS
Anticoagulation in Acute Ischemic Stroke. TPA: Tissue Plasminogen Activator 1995: NINDS study of TPA administration Design: randomized, double blind placebo-controlled.
E. Bradshaw Bunney, MD Stroke Care within the 3 Hour IV tPA Window: Why IV tPA, or What Alternatives?
Mid America Stroke Network Founded By: Saint Louis University Hospital (SLU Hospital)
Stroke Systems Improved Outcomes? E. Bradshaw Bunney, MD, FACEP.
Andy Jagoda, MD, FACEP Stroke and TIA Patients in the Prehospital and ED Settings: Should EMS Triage and Inter-hospital Transfer to Stroke Centers Take.
TPA in Acute Ischemic Stroke: The NINDS Reanalysis & Meta-analysis Data Sidney Starkman, MD, FACEP.
T-PA in Treatment of Acute Stroke: What We Know From NINDS 2004 vs 2000 Sidney Starkman, MD Departments of Emergency Medicine and Neurology, UCLA UCLA.
Acute Stroke Management in Northern Nevada and the Sierra Slopes A Model for Rural Stroke Care Paul M. Katz, M.D. Medical Director Washoe Comprehensive.
Stroke Alert at Lutheran General Hospital, Park Ridge, IL
FERNE/MEMC Session: Treating Ischemic Stroke in the 3 – 4
The Future of Stroke in Your State: Kansas Janice Sandt MS,BSN,RN,CCM FINANCIAL DISCLOSURES: None UNLABELED/UNAPPROVED USES DISCLOSURE: None.
Systems in Acute Stroke Care Andy Jagoda, MD Professor of Emergency Medicine Department of Emergency Medicine Mount Sinai School of Medicine New York,
Edward P. Sloan, MD, MPH FERNE/EMA Session: Treating Ischemic Stroke Patients Using a 3 to 4.5 Hour tPA Window.
Acute Ischemic Stroke Management: 2004 Emergency Medicine Perspectives.
Clinical Use of tPA in Acute Ischemic Stroke. Edward P. Sloan, MD, MPH Associate Professor Department of Emergency Medicine University of Illinois College.
Clinical Use of tPA in Acute Ischemic Stroke Edward P. Sloan, MD, MPH Associate Professor Department of Emergency Medicine University of Illinois College.
Edward P. Sloan, MD, MPH IEME/FERNE Case Conference: Legal Issues in the ED Management of Acute Ischemic Stroke Patients.
Preparing for Stroke Certification
Dr : Osama Badry Cardiology /Anticogaulation Coordinator Incharge of Anticoagulation Service AWH-HMC/Qatar.
VBWG CHARISMA Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance trial.
Around-the-Clock Primary Angioplasty: A Process of Care Analysis Comparing Off-Hours and Normal Hours Treatment of Acute STEMI R Leung, D Lundberg, D Galbraith,
Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: National Assessment of ED Pediatric Readiness Gausche-Hill M, Ely M, Schmuhl P, et.
Interventions in Acute Ischemic Stroke: Strategies for the New Millennium For the next 25 minutes, we will spend sometime talking about Neuroimaging.
The Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Brief Protocol Training NIH-NINDS U01 NS NETT CCC U01 NS NETT SDMC U01 NS
The Ontario Stroke Strategy Southeastern Ontario (SEO) Jan 2006 Cally Martin, BScPT, MSc(Rehab) Regional Stroke Coordinator, SEO Tamara Lucas RN, BNSc,
Maximizing IV Thrombolytic Therapy in Acute Ischemic Stroke Kamakshi Lakshminarayan, MD PhD Assistant Professor Neurology & Epidemiology University of.
Stroke and the ED Kurian Thomas, MD Department of Neurology.
TIMI 11A A Multicenter Trial of the Safety and Tolerability of Two Doses of Enoxaparin in Patients With Unstable Angina and Non-Q-Wave Myocardial Infarction.
The Evolving Management of Pediatric Stroke Christopher A. Miller, MD July 21, 2012.
10 May 2005 CASES - Original article available at CASES (Canadian Alteplase for Stroke Effectiveness Study) The CASES Investigators.
Thrombolysis in acute ischaemic stroke – Updated Cochrane Thrombolysis metaanalysis JM Wardlaw, V Murray, PAG Sandercock University of Edinburgh and Karolinska.
National Heart, Lung, and Blood Institute Women’s Health Initiative Branch Jacques Rossouw, MD Chief, WHI Branch Program for Prevention and Population.
The Acute Stroke Menu: Something off the Back Page Innovative ways to use IV t-pa and other assorted therapies available outside the standard treatment.
Mr X, 79 years old Admitted on 5/5/00 to WGH stroke unit Dense (0/5) right arm and leg paresis Aphasic CT scan excluded a bleed Given trial treatment (IST-3)
11 Mayview Regional Service Area Plan (MRSAP) Tracking: Supporting Individuals in the Community June 18, 2008.
A Practice-Based Intervention to Improve Time-to-Antibiotic Administration in Pneumonia Suspects at Mulago Hospital, Kampala, Uganda Luke Davis, MD Pulmonary.
The Use of tPA in Acute Ischemic Stroke Edward P. Sloan, MD, MPH Professor Department of Emergency Medicine University of Illinois College of Medicine.
Richard Shih, MD, FACEP Stroke Patient Management Using IV tPA: When and How Should It Be Utilized in ED Patients?
NSTE Acute Coronary Syndromes
VBWG OASIS-6 The Sixth Organization to Assess Strategies in Acute Ischemic Syndromes trial.
Clinical Use of tPA in Acute Ischemic Stroke Edward P. Sloan, MD, MPH Associate Professor Department of Emergency Medicine University of Illinois College.
D Monnery, R Ellis, S Hammersley Leighton Hospital, Crewe.
Broward EMS Stroke Coalition Brijesh P Mehta, M.D. NeuroInterventional Surgeon Director, Stroke & Neurocritical Care Memorial Neuroscience Institute.
Dr Marc Randall Consultant Neurologist and Stroke Physician Honorary Senior Lecturer University Sheffield.
Jason P. Lott, Theodore J. Iwashyna, Jason D. Christie, David A. Asch, Andrew A. Kramer, and Jeremy M. Kahn Am J Respir Crit Care Med Vol 179. pp 676–683,
Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated with Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation.
Advances in Treatment for Acute Stroke
Treating Acute Ischemic Stroke, Can We Open Up the Time Window?
Table 1: Table 2: Non Therapeutic Angiograms in Acute Ischemic Stroke Patients Being Considered for Endovascular Treatment Does not Adversely Affect Patient.
Clinical Audit of Head CT in Stroke Alert Cases: Role of Radiology Resident and CT Technologist Awareness in improving Head CT reporting time K Hooda,
SOCRATES Trial design: Patients with acute ischemic stroke were randomized in a 1:1 fashion to receive either ticagrelor 180 mg load + 90 mg BID or aspirin.
Acute Hypertension Management Optimizing Door-to-Needle Time in Ischemic Stroke.
Performance Improvement: Emergency Management in Acute Cerebrovascular Patients Current US Guidelines Lisa A. Shultz, MD Medical Director, Lourdes Stroke.
Annals of Internal Medicine • Vol. 167 No. 12 • 19 December 2017
In this study since they are going to be exploring how differences in suicide attempts are associated with the outcomes they in addition to describing.
Extended Window Thrombectomy
Stroke Protocols Ensure Efficient Patient Intake, Diagnosis, Treatment
Presentation transcript:

CLEVELAND ACUTE STROKE EXPERIENCE Cleveland Health Quality Choice –stroke data collected by trained abstractors since 1991 –IV tPA datapoints added 1996 –disbanded 1998 Cuyahoga County Operation Stroke 1999 –data collection instrument designed by the Medical Committee and The Stroke Group (ETHOS R ) grants from Genentech/Astra Zeneca Cleveland Clinic Health System Stroke QI Program –presented to JCAHO 4/01

Cleveland Health Quality Choice IV tPA Utilization: Ischemic Strokes July June 1998 n=4275 n=70 tPA 1.8% No tPA 98.2% Katzan IL etal. JAMA 2000;283:1151

Cleveland Health Quality Choice IV tPA Utilization by Hospital July June 1998 Katzan IL etal. JAMA 2000;283:1151 N = 27 (N = 70)

Cleveland Health Quality Choice IV tPA Symptomatic Intracranial Hemorrhage (ICH) July June 1998 n = 59 n = 11 Symptomatic ICH 15.7%* * 95% CI 8.1% % Katzan IL etal. JAMA 2000;283:1151

Cleveland Health Quality Choice IV tPA: Identified Protocol Deviations July June 1998 Antithrombotics < 24hr 65% Beyond Time Window 22.5% High Blood Pressure 12.5% Katzan IL etal. JAMA 2000;283:1151 Deviations in 50%

Intracranial Hemorrhage after IV tPA

Connecticut IV tPA experience (Bravata DM etal. Arch Intern Med 2002;162:1994) Retrospective cohort of 16 community based hospitals 5/96-12/98 67% (42/63) major protocol deviations –dosing errors –>3 hours –known increased bleeding risk (eg low platelets) Serious extracranial hemorrhage 17% (NINDS 2%) In-hospital mortality 31% (NINDS 13%)

Cuyahoga County Operation Stroke Door to Doctor 1/00 - 3/01 (N=65)(N=224)(N=253)(N=65)(N=692)(N=101)(N=59) Katzan IL etal. Stroke 2003 in press

Cuyahoga County Operation Stroke Time to Initiation of CT 1/00 - 3/01 (N=56)(N=241)(N=262)(N=53)(N=671)(N=78)(N=58) Katzan IL etal. Stroke 2003 in press

Center line = median, box=25-75% quartiles, whiskers=1.5x interquartile range Katzan IL etal. Stroke 2003 in press Cuyahoga County Operation Stroke

Cleveland Clinic Health System Stroke Quality Improvement Program Symptomatic Intracranial Hemorrhage Symptomatic ICH 13.8%* n=4 No symptomatic ICH 86.2% n=25 *95% CI = 5.5% % 7/97-6/98 CHQC

CLEVELAND ACUTE STROKE EXPERIENCE Stroke QI requires data –quality of data varies (many hospitals = no data) –multiple barriers must be overcome (behavioral, political, resources) –team building through trust building Performance varies widely across hospitals –physicians and hospitals may not like their data –outliers may not mean bad care –community effectiveness may differ from NINDS efficacy Protocol deviations are very common – linked with bad outcomes Data can change behavior and improve stroke care –community performance improves over time with systematic QI Community hospitals can & should give IV tPA IF they are able to demonstrate they know how